Literature DB >> 20232189

Risk messages about HPV, cervical cancer, and the HPV vaccine gardasil in North American news magazines.

Nazek Abdelmutti1, Laurie Hoffman-Goetz.   

Abstract

The human papillomavirus (HPV) vaccine (Gardasil) is a significant advancement in reducing women's risk for cervical cancer. Public opinion of the vaccine can be influenced by the mass media. We used content analysis to assess the discussion of risks, fear-inducing messages about HPV, cervical cancer, and the HPV vaccine in four high circulating North American news magazines from January 2006 to December 2007. Risk messages about HPV and cervical cancer focused on threatening illness or injury. Reporting on the HPV vaccine emphasized it being poorly understood by science. News magazine articles on the HPV vaccine and cervical cancer included fear-inducing messages. Cancer educators need to be aware of media reporting in order to alleviate fears that the public may experience about the HPV vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232189     DOI: 10.1007/s13187-010-0087-9

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  11 in total

1.  Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control.

Authors:  G D Zimet; R M Mays; J D Fortenberry
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

2.  Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996.

Authors:  Edward Ng; Russell Wilkins; Michael Fung Kee Fung; Jean-Marie Berthelot
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

3.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

4.  Statement on human papillomavirus vaccine. An Advisory Committee Statement (ACS).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2007-02-15

Review 5.  Ethical analysis of HPV vaccine policy options.

Authors:  Richard K Zimmerman
Journal:  Vaccine       Date:  2006-03-23       Impact factor: 3.641

6.  Preferences for sources of information about abnormal Pap tests and HPV in women tested for HPV.

Authors:  Donna Hubbard McCree; Patricia A Sharpe; Heather M Brandt; Rashanda Robertson
Journal:  Prev Med       Date:  2006-05-15       Impact factor: 4.018

Review 7.  Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.

Authors:  Kathleen M Vetter; Stacie E Geller
Journal:  J Womens Health (Larchmt)       Date:  2007-11       Impact factor: 2.681

8.  News media coverage of human papillomavirus.

Authors:  Rebecca Anhang; Jo Ellen Stryker; Thomas C Wright; Sue J Goldie
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

9.  Women's desired information about human papillomavirus.

Authors:  Rebecca Anhang; Thomas C Wright; Laura Smock; Sue J Goldie
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

Review 10.  Appropriate use of cervical cancer vaccine.

Authors:  Gregory D Zimet; Marcia L Shew; Jessica A Kahn
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

View more
  10 in total

1.  The role of media and the Internet on vaccine adverse event reporting: a case study of human papillomavirus vaccination.

Authors:  Jan M Eberth; Kimberly N Kline; David A Moskowitz; Jane R Montealegre; Michael E Scheurer
Journal:  J Adolesc Health       Date:  2013-11-17       Impact factor: 5.012

2.  Topics associated with conflict in print news coverage of the HPV vaccine during 2005 to 2009.

Authors:  Dana M Casciotti; Katherine C Smith; Ann Carroll Klassen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Diverse Families' Experiences with HPV Vaccine Information Sources: A Community-Based Participatory Approach.

Authors:  Djin Lai; Julia Bodson; France A Davis; Doriena Lee; Fahina Tavake-Pasi; Edwin Napia; Jeannette Villalta; Valentine Mukundente; Ryan Mooney; Heather Coulter; Louisa A Stark; Ana C Sanchez-Birkhead; Deanna Kepka
Journal:  J Community Health       Date:  2017-04

4.  Predictors of cancer fear: the association between mass media and fear of cancer among cancer diagnosed and nondiagnosed individuals.

Authors:  Sara Nelissen; Kathleen Beullens; Marijke Lemal; Jan Van den Bulck
Journal:  J Cancer Educ       Date:  2015-03       Impact factor: 2.037

5.  Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013).

Authors:  Gina S Ogilvie; Felicia Phan; Heather N Pedersen; Simon R Dobson; Monika Naus; Elizabeth M Saewyc
Journal:  CMAJ       Date:  2018-10-15       Impact factor: 8.262

6.  Social media study of public opinions on potential COVID-19 vaccines: informing dissent, disparities, and dissemination.

Authors:  Hanjia Lyu; Junda Wang; Wei Wu; Viet Duong; Xiyang Zhang; Timothy D Dye; Jiebo Luo
Journal:  Intell Med       Date:  2021-08-25

7.  Discussions of adolescent sexuality in news media coverage of the HPV vaccine.

Authors:  Dana M Casciotti; Katherine C Smith; Amy Tsui; Ann C Klassen
Journal:  J Adolesc       Date:  2013-12-10

8.  Skin deep: Coverage of skin cancer and recreational tanning in Canadian women's magazines (2000-2012).

Authors:  Jennifer E McWhirter; Laurie Hoffman-Goetz
Journal:  Can J Public Health       Date:  2015-06-18

9.  Understanding the role of the news media in HPV vaccine uptake in the United States: Synthesis and commentary.

Authors:  Sarah E Gollust; Susan M LoRusso; Rebekah H Nagler; Erika Franklin Fowler
Journal:  Hum Vaccin Immunother       Date:  2015-11-10       Impact factor: 3.452

10.  Content analysis of digital media coverage of the human papillomavirus vaccine school-entry requirement policy in Puerto Rico.

Authors:  Vivian Colón-López; Vilnery Rivera-Figueroa; Glizette O Arroyo-Morales; Diana T Medina-Laabes; Roxana Soto-Abreu; Manuel Rivera-Encarnación; Olga L Díaz-Miranda; Ana P Ortiz; Katelyn B Wells; Coralia Vázquez-Otero; Pamela C Hull
Journal:  BMC Public Health       Date:  2021-07-01       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.